These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome]. Hidasi E; Soltész P Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015 [TBL] [Abstract][Full Text] [Related]
11. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange]. Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991 [TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of chronic Guillain-Barré syndrome with high dose IgG and cyclosporin A. Case report, review of the literature and perspectives]. Müllges W; Ringelstein EB; Sommer C; Biniek R; Glöckner WM Fortschr Neurol Psychiatr; 1991 May; 59(5):183-9. PubMed ID: 1869236 [TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis in 2 children with Guillain-Barré syndrome]. Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585 [TBL] [Abstract][Full Text] [Related]
14. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome]. Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643 [TBL] [Abstract][Full Text] [Related]
17. Plasma exchange and selective adsorption in Guillain-Barré syndrome--a comparison of therapies by clinical course and side effects. Rosenow F; Haupt WF; Grieb P; Jiménez-Klingberg C; Borberg H Transfus Sci; 1993 Jan; 14(1):13-5. PubMed ID: 10148310 [TBL] [Abstract][Full Text] [Related]
18. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome. Sanjay R; Flanagan J; Sodano D; Gorson KC; Ropper AH; Weinstein R J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192 [TBL] [Abstract][Full Text] [Related]
19. Management and outcome of severe Guillain-Barré syndrome. Ng KK; Howard RS; Fish DR; Hirsch NP; Wiles CM; Murray NM; Miller DH QJM; 1995 Apr; 88(4):243-50. PubMed ID: 7796073 [TBL] [Abstract][Full Text] [Related]
20. Unintended plasma exchange therapy in poliomyelitis: difficulties in the differential diagnosis of paralytic poliomyelitis and polyradiculitis. Färkkilä M; Kinnunen E; Hovi T; Iivanainen M Ann Clin Res; 1987; 19(6):395-8. PubMed ID: 3451693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]